NR vs NMN: Which NAD+ Booster Is Better?

Short answer first. For raising NAD+ in your blood, NR and NMN work about the same. That is not a marketing line, it is what the first direct human comparison found.

Where the two really differ is everything around the molecule: how long they have been studied, what regulators allow, what they cost, and how hard each one is being sold to you.

None of those differences change what the supplement does in your body. This guide runs through the evidence, the mechanism, the practical differences, and the doses that were tested.

TL;DR

• NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are both vitamin B3-derived NAD+ precursors.
• In the first head-to-head human trial (65 people, 14 days), they raised blood NAD+ to the same degree [1].
• No trial has shown either one beating the other on a health outcome. Meta-analyses are flat on muscle, strength and metabolic markers [2][4].
• Both appear to work partly through gut bacteria rather than being absorbed intact, which weakens the old “NMN is closer to NAD+, so it must be better” pitch [1].
• Tested doses: 300–1,000 mg a day for NR, 250–500 mg for NMN.
• One real practical difference: NR has been an authorised novel food in the EU since January 2020, while NMN spent three years excluded from the US supplement definition and is still a grey area in Europe [8].
• Neither replaces training, protein, sleep or treatment for a diagnosed condition.

What NR and NMN are

Both are forms of vitamin B3. Your body uses B3 to build NAD+, a cofactor cells need for energy production and DNA repair, and which declines with age. If you want the wider picture on that decline, and why the marketing charts exaggerate it, read our NAD+ guide for people over 40.

On paper the pathway looks simple:

• NR → NMN → NAD+
• NMN → NAD+

That diagram is why NMN built a reputation as the more direct option. One enzymatic step instead of two. The catch: the diagram describes what happens inside a cell, not what happens after you swallow a capsule.

The head-to-head study that changed the argument

For years the honest answer to “NR or NMN?” was that nobody had compared them properly in humans. That changed with a 2026 trial in Nature Metabolism [1].

The design: 65 healthy adults, 14 days, randomized and placebo-controlled, with NR, NMN and plain nicotinamide (Nam) run against each other.

Here we show in a randomized, open-label, placebo-controlled study in 65 healthy participants that 14 days of supplementation with NR and NMN, but not Nam, comparably increases circulatory NAD+ concentrations in healthy adults.

[1], Nature Metabolism, 2026

Two findings in that paper matter more than the headline.

First, the gut. When the researchers fermented the precursors with human gut bacteria, both NR and NMN broke down into nicotinic acid, and nicotinic acid turned out to be the strong NAD+ booster in whole blood. NMN, NR and nicotinamide themselves were not [1].

That points to a gut-dependent model. You swallow NR or NMN, your microbiome converts part of it, and the metabolite does much of the work. It also means two people taking the same capsule can get different results, depending on what is living in their gut.

Second, the funding. The study team included employees of Nestlé Research, a company with a commercial interest in NR. That does not make the result wrong. It is peer reviewed and it does not favour NMN either. It is just one good study, not the final word.

What the outcome studies show

Raising a blood marker is not a benefit. Here is where both precursors stand on outcomes people care about.

Muscle and strength. A 2025 meta-analysis pooled randomized trials in adults aged roughly 61 to 83. NMN showed no effect on muscle mass index, grip strength, gait speed or the chair-stand test. NR produced a longer six-minute walk in people with peripheral artery disease, but worse physical performance scores in people with mild cognitive impairment [2].

Current evidence does not support NMN and NR supplementation for preserving muscle mass and function in adults with mean age of over 60 years.

[2], Journal of Cachexia, Sarcopenia and Muscle, 2025

Cognition. A 2026 randomized pilot gave NR to 42 adults with amnestic mild cognitive impairment for 12 weeks. Blood NAD+ doubled. Cognitive function, total cerebral blood flow and blood pressure did not improve [3].

That is the pattern in almost every trial. The marker moves, the outcome does not.

Metabolic markers. A 2026 meta-analysis of oral NMN trials found no broad metabolic benefits, with small diastolic blood pressure and insulin-resistance signals in older adults and people with early metabolic risk [4].

Cholesterol. You may see NR or NMN credited with better lipids, based on a large 2022 meta-analysis of NAD+ precursors [5]. Read the fine print. That literature is dominated by nicotinic acid, the prescription-strength form of niacin used as a drug. Niacin’s cholesterol results are not something NR or NMN have ever demonstrated.

One industry claim to park. A 2026 paper reports that a specific NR salt beats plain NMN and NR chloride at matched doses [6]. The paper comes from the company behind that formulation and no independent group has replicated it. Until one does, it is a product claim, not a comparison of NR and NMN.

NR vs NMN side by side

	NR (nicotinamide riboside)	NMN (nicotinamide mononucleotide)
What it is	B3-derived, converted to NMN before NAD+	B3-derived, one step from NAD+
Blood NAD+ in humans	Rises	Rises, equal to NR in the direct comparison [1]
Human trial record	Longer: trials since the mid-2010s, in a wider range of populations [3]	Larger recent volume: safety meta, muscle meta, blood pressure meta [2][4]
Effect on outcomes	Flat on cognition, muscle and metabolic markers	Flat on muscle and metabolic markers; small diastolic BP signal
Typical tested dose	300–1,000 mg a day	250–500 mg a day
US regulatory status	Lawful supplement ingredient	Excluded from the supplement definition in 2022, reinstated in late 2025 [8]
EU status	Authorised novel food as NR chloride since January 2020 [8]	Still treated as an unauthorised novel food
Price	Usually cheaper per gram	Often several times the price per gram
Marketing pressure	Moderate	Heavy

Safety and side effects

Both have clean short-term records at trial doses.

• The 2026 NMN meta-analysis found no increase in adverse events, serious adverse events or liver enzyme changes across 15 trials [4].
• The NR pilot in mild cognitive impairment reported no serious adverse effects and adherence similar to placebo [3].

What is genuinely unknown:

• Long term. The longest NMN safety data cover about 24 weeks. Nobody has run a five-year trial.
• Cancer. Human data do not exist, and rodent studies point in both directions.
• Pregnancy and breastfeeding. Unstudied. Avoid.
• Interactions with medication. Never tested. If you take prescription drugs, ask your pharmacist first.

One more caveat from the science: NAD+ responses are not linear. A 2026 review points out that dose, age, metabolic state and route of administration all shift the response, and that feedback mechanisms and saturation are real [7]. Doubling your dose does not double your NAD+.

So which one should you buy?

Work down this list and stop when you run out of reasons.

1. Fix the basics first. Sleep, protein, resistance training and treatment for any diagnosed condition beat both supplements. Start with our guide to better sleep after 40 if sleep is your weak spot.
2. Choose on price and testing, not on the name. At matched trial-range doses there is no outcome data separating NR from NMN. Plain capsules from a brand that publishes third-party testing win.
3. Prefer NR if paperwork and regulation matter to you. It has been authorised in the EU since 2020 and has the longer human record. In the US, both are now lawful.
4. Skip the premium formats. Sublingual, “enhanced absorption” and bottles at ten times the price are not supported by the comparisons that exist.
5. Do not test your NAD+ levels. Consumer NAD+ tests are not standardized and the number is not a health outcome. Our NAD+ guide for people over 40 covers why the “check your levels” pitch deserves suspicion.
6. If you want a stronger human signal, look elsewhere. Urolithin A has more consistent muscle-function results, and creatine has better strength and brain data than either precursor.

For the molecule-level detail on NMN, including forms, labels and how the trials were dosed, see NMN explained.

FAQ

Is NMN legal to buy in the US?

Yes, again. The FDA excluded NMN from the US supplement definition in late 2022, and Amazon pulled it from its shelves. In September 2025 the agency reversed that position, and its December 2025 letter set the 2022 decision aside, so NMN is lawful again in the US [8]. In the EU and UK, sellers still work under novel-food rules, which is why NMN is harder to find there.

Can you take NR and NMN together?

No trial has tested the combination. Since both appear to feed the same pathway, and part of the effect runs through gut conversion, stacking them is expensive duplication rather than synergy. The same applies to patented pairings such as PQQ plus NMN or NR: a 2026 review found the evidence for additive anti-aging effects is still limited [9].

How much NR or NMN should you take a day?

Stay inside the tested range: 300–1,000 mg a day for NR, 250–500 mg for NMN. That is where the safety data come from. Higher doses have no outcome evidence behind them, and NAD+ synthesis appears to saturate rather than scale [7].

Is NR the same as niacin?

No. Both are vitamin B3 forms, but niacin (nicotinic acid) flushes your skin and, at the gram doses used for cholesterol, is a prescription-level drug with real liver and blood-sugar effects. NR does not flush, and supplement doses are far lower. Do not assume niacin’s cholesterol results transfer to NR or NMN [5].

Which one has more human trial evidence?

NR has the longer record: human trials since the mid-2010s, in a wider range of populations, including mild cognitive impairment [3], psoriasis and ataxia-telangiectasia. NMN has caught up in volume over the past few years. Neither is ahead where it counts, because neither has beaten placebo on a meaningful clinical outcome.

References & sources (11)

References

1. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism, 2026. PMID 41540253
2. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 2025. PMID 40275690
3. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. Alzheimer’s & Dementia, 2026. PMID 42478598
4. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients, 2026. PMID 42514320
5. Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis. Nutrition & Metabolism, 2022. PMID 35303905
6. Restorin NR is a Highly Efficient NAD+ Precursor. Drug Design, Development and Therapy, 2026. PMID 42582917
7. NAD+ biology and supplementation: From mechanisms to clinical perspectives. Molecular Biology Reports, 2026. PMID 42489969
8. FDA correspondence on the regulatory status of β-nicotinamide mononucleotide, September and December 2025 (regulations.gov FDA-2023-P-0872); Commission Implementing Regulation (EU) 2020/16 authorising nicotinamide riboside chloride as a novel food.
9. Comparison of anti-aging effect of PQQ (Pyrroloquinoline quinone) and NMN/NR (Nicotinamide mononucleotide/Nicotinamide riboside) – possible combination use. Ageing Research Reviews, 2026. PMID 41390101
10. NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis. JCI Insight, 2026. PMID 42048163
11. Transcriptional Profiling Shows Dampening of Interferon Gene Signatures by NAD+ Augmentation in Ataxia-Telangiectasia. International Journal of Molecular Sciences, 2026. PMID 42449929

This article is for general information and is not medical advice. It does not replace the advice of your doctor or pharmacist. Talk to a qualified clinician before starting any supplement, especially if you take prescription medication, have a health condition, or are pregnant or breastfeeding.